AIRLINK 166.56 Decreased By ▼ -1.95 (-1.16%)
BOP 9.73 Decreased By ▼ -0.06 (-0.61%)
CNERGY 7.85 Decreased By ▼ -0.14 (-1.75%)
CPHL 88.53 Increased By ▲ 0.56 (0.64%)
FCCL 43.40 Decreased By ▼ -0.53 (-1.21%)
FFL 15.47 Decreased By ▼ -0.05 (-0.32%)
FLYNG 28.00 Increased By ▲ 0.06 (0.21%)
HUBC 137.13 Decreased By ▼ -0.84 (-0.61%)
HUMNL 12.36 Decreased By ▼ -0.01 (-0.08%)
KEL 4.20 Decreased By ▼ -0.04 (-0.94%)
KOSM 5.60 Increased By ▲ 0.04 (0.72%)
MLCF 64.99 Increased By ▲ 0.20 (0.31%)
OGDC 210.25 Decreased By ▼ -1.44 (-0.68%)
PACE 5.67 Decreased By ▼ -0.06 (-1.05%)
PAEL 44.21 Decreased By ▼ -0.81 (-1.8%)
PIAHCLA 17.15 Increased By ▲ 0.06 (0.35%)
PIBTL 9.27 Increased By ▲ 0.04 (0.43%)
POWER 14.11 Decreased By ▼ -0.34 (-2.35%)
PPL 165.00 Decreased By ▼ -1.40 (-0.84%)
PRL 30.36 Decreased By ▼ -0.29 (-0.95%)
PTC 20.92 Decreased By ▼ -0.28 (-1.32%)
SEARL 90.00 Decreased By ▼ -0.47 (-0.52%)
SSGC 40.40 Decreased By ▼ -0.65 (-1.58%)
SYM 14.56 Increased By ▲ 0.08 (0.55%)
TELE 7.26 Decreased By ▼ -0.13 (-1.76%)
TPLP 9.18 Decreased By ▼ -0.19 (-2.03%)
TRG 65.20 Increased By ▲ 0.20 (0.31%)
WAVESAPP 9.30 Decreased By ▼ -0.21 (-2.21%)
WTL 1.31 No Change ▼ 0.00 (0%)
YOUW 3.71 Decreased By ▼ -0.01 (-0.27%)
AIRLINK 166.56 Decreased By ▼ -1.95 (-1.16%)
BOP 9.73 Decreased By ▼ -0.06 (-0.61%)
CNERGY 7.85 Decreased By ▼ -0.14 (-1.75%)
CPHL 88.53 Increased By ▲ 0.56 (0.64%)
FCCL 43.40 Decreased By ▼ -0.53 (-1.21%)
FFL 15.47 Decreased By ▼ -0.05 (-0.32%)
FLYNG 28.00 Increased By ▲ 0.06 (0.21%)
HUBC 137.13 Decreased By ▼ -0.84 (-0.61%)
HUMNL 12.36 Decreased By ▼ -0.01 (-0.08%)
KEL 4.20 Decreased By ▼ -0.04 (-0.94%)
KOSM 5.60 Increased By ▲ 0.04 (0.72%)
MLCF 64.99 Increased By ▲ 0.20 (0.31%)
OGDC 210.25 Decreased By ▼ -1.44 (-0.68%)
PACE 5.67 Decreased By ▼ -0.06 (-1.05%)
PAEL 44.21 Decreased By ▼ -0.81 (-1.8%)
PIAHCLA 17.15 Increased By ▲ 0.06 (0.35%)
PIBTL 9.27 Increased By ▲ 0.04 (0.43%)
POWER 14.11 Decreased By ▼ -0.34 (-2.35%)
PPL 165.00 Decreased By ▼ -1.40 (-0.84%)
PRL 30.36 Decreased By ▼ -0.29 (-0.95%)
PTC 20.92 Decreased By ▼ -0.28 (-1.32%)
SEARL 90.00 Decreased By ▼ -0.47 (-0.52%)
SSGC 40.40 Decreased By ▼ -0.65 (-1.58%)
SYM 14.56 Increased By ▲ 0.08 (0.55%)
TELE 7.26 Decreased By ▼ -0.13 (-1.76%)
TPLP 9.18 Decreased By ▼ -0.19 (-2.03%)
TRG 65.20 Increased By ▲ 0.20 (0.31%)
WAVESAPP 9.30 Decreased By ▼ -0.21 (-2.21%)
WTL 1.31 No Change ▼ 0.00 (0%)
YOUW 3.71 Decreased By ▼ -0.01 (-0.27%)
BR100 12,236 Decreased By -19 (-0.16%)
BR30 36,549 Decreased By -174.1 (-0.47%)
KSE100 114,876 Decreased By -143.7 (-0.12%)
KSE30 35,271 Decreased By -57.3 (-0.16%)

US FDA

US FDA expected to authorize Pfizer vaccine for 12-15-year-olds soon
World

US FDA expected to authorize Pfizer vaccine for 12-15-year-olds soon

  • The approval is highly anticipated after the drugmaker said in March the vaccine was found to be safe, effective and produced a robust antibody responses in 12- to 15-year-olds in a clinical trial.
  • The vaccine has already been cleared in the United States for those aged 16 and above.
Published 05 May, 2021 06:26pm
Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab
Business & Finance

Lilly asks FDA to not allow lone use of COVID-19 drug bamlanivimab

  • The request made to the US Food and Drug Administration is not due to any new safety issues, but in response to the new variants in the country that could be resistant to bamlanivimab when used alone, the drugmaker said in a statement.
  • Hospitals with bamlanivimab supply should now order etesevimab to pair with it, Lilly said.
Published 16 Apr, 2021 05:45pm